I wouldn't go that far at this point. IMO It's a potential winner - not a gold mine (yet). The selling point right now is cheap public ownership (shares) available for a company that may have a major therapeutic breakthrough in a few years. Current revenue increases from their existing business will be off-set by the cost of conducting human trials. So "gold mine" is hard to consider right now. The upside if all goes well though is absolutely enormous!
News 
Market Data 
Discover 
AI
